Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cyrielle Gasc

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Applied and Environmental Microbiology|April 23, 2024
Reduction of product composition variability using pooled microbiome ecosystem therapy and consequence in two infectious murine modelsJulie Reygner, Johanne Delannoy, Marie-Thérèse Barba-Goudiaby, et al.
Frontiers in Medicine|March 22, 2021
Impact on the Gut Microbiota of Intensive and Prolonged Antimicrobial Therapy in Patients With Bone and Joint InfectionBenoît Levast, Nicolas Benech, Cyrielle Gasc, et al.
Blood Advances|April 8, 2025
Gut microbiota restoration with oral pooled fecal microbiotherapy after intensive chemotherapy: the phase Ib CIMON trialFlorent Malard, Sylvain Thepot, Thomas Cluzeau, et al.
Nature Communications|May 26, 2021
Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patientsFlorent Malard, Anne Vekhoff, Simona Lapusan, et al.
Eclinicalmedicine|September 1, 2023
Pooled allogeneic faecal microbiota MaaT013 for steroid-resistant gastrointestinal acute graft-versus-host disease: a single-arm, multicentre phase 2 trialFlorent Malard, Michael Loschi, Anne Huynh, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Applied and Environmental Microbiology|April 23, 2024
Reduction of product composition variability using pooled microbiome ecosystem therapy and consequence in two infectious murine modelsJulie Reygner, Johanne Delannoy, Marie-Thérèse Barba-Goudiaby, et al.
Frontiers in Medicine|March 22, 2021
Impact on the Gut Microbiota of Intensive and Prolonged Antimicrobial Therapy in Patients With Bone and Joint InfectionBenoît Levast, Nicolas Benech, Cyrielle Gasc, et al.
Blood Advances|April 8, 2025
Gut microbiota restoration with oral pooled fecal microbiotherapy after intensive chemotherapy: the phase Ib CIMON trialFlorent Malard, Sylvain Thepot, Thomas Cluzeau, et al.
Nature Communications|May 26, 2021
Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patientsFlorent Malard, Anne Vekhoff, Simona Lapusan, et al.
Eclinicalmedicine|September 1, 2023
Pooled allogeneic faecal microbiota MaaT013 for steroid-resistant gastrointestinal acute graft-versus-host disease: a single-arm, multicentre phase 2 trialFlorent Malard, Michael Loschi, Anne Huynh, et al.
Pageof 3